🇪🇺 Celsentri® in European Union

EMA authorised Celsentri® on 18 September 2007

Marketing authorisation

EMA — authorised 18 September 2007

  • Application: EMEA/H/C/000811
  • Marketing authorisation holder: ViiV Healthcare B.V.
  • Local brand name: Celsentri
  • Indication: Celsentri, in combination with other antiretroviral medicinal products, is indicated for treatment experienced adults, adolescents and children of 2 years of age and older and weighing at least 10 kg infected with only CCR5-tropic HIV-1 detectable
  • Status: approved

Read official source →

Other Infectious Disease approved in European Union

Frequently asked questions

Is Celsentri® approved in European Union?

Yes. EMA authorised it on 18 September 2007.

Who is the marketing authorisation holder for Celsentri® in European Union?

ViiV Healthcare B.V. holds the EU marketing authorisation.